Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

3.6%

2 terminated/withdrawn out of 56 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

13%

7 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

23 recruiting

Enrollment Performance

Analytics

N/A
23(53.5%)
Phase 2
10(23.3%)
Phase 3
5(11.6%)
Early Phase 1
3(7.0%)
Phase 4
2(4.7%)
43Total
N/A(23)
Phase 2(10)
Phase 3(5)
Early Phase 1(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (56)

Showing 20 of 56 trials
NCT07550205Phase 2Not Yet Recruiting

Tiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian Cancer

Role: collaborator

NCT07523308Not ApplicableNot Yet Recruiting

Efficacy and Safety of Intra-operative Dual Laparoscopy and Neo-rectoscopy vs Conventional Laparoscopy for Bowel Endometriosis: The LUMEN-01 Trial

Role: lead

NCT06836869Not ApplicableRecruiting

Modified Tumor-free Techniques Operation to Cervical Cancer

Role: collaborator

NCT07434284Early Phase 1Recruiting

Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies

Role: lead

NCT07369284Phase 2Not Yet Recruiting

Melatonin for Glycemic Control in Gestational Diabetes Mellitus

Role: lead

NCT07318701Not ApplicableNot Yet Recruiting

Multi-agent LLMs for Decision Support in Cervical Cancer During Pregnancy

Role: lead

NCT07261683Phase 2Recruiting

Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer

Role: lead

NCT05454358Phase 2Terminated

Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP

Role: collaborator

NCT07240753Not Yet Recruiting

A Chinese Cohort of Cervical Large Cell Neuroendocrine Carcinoma

Role: collaborator

NCT07202728Recruiting

A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01)

Role: lead

NCT07050563Not ApplicableNot Yet Recruiting

Clinical Evaluation of the Tiaoshen Anti-Cancer Regimen in Treating Psycho-Neurological Symptom Cluster in Ovarian Cancer

Role: collaborator

NCT07170254Not ApplicableRecruiting

A Clinical Study on the Evaluation of BD114 for the Treatment HPV-16-Related Cervical HSIL

Role: collaborator

NCT04555226Not ApplicableRecruiting

The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)

Role: collaborator

NCT06781151Recruiting

A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB

Role: collaborator

NCT07130240Phase 2Recruiting

Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer

Role: lead

NCT07039097Not ApplicableRecruiting

A Multicenter, Prospective, Randomized, Controlled Clinical Study on the Effect of Hysteroscopic Uterine Septum Resection on the Natural Pregnancy Outcomes in Patients With Non-recurrent Spontaneous Abortion

Role: collaborator

NCT05179447Not ApplicableRecruiting

PROfiling Based Endometrial Cancer Adjuvant Therapy

Role: collaborator

NCT06904131Not ApplicableRecruiting

A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors

Role: lead

NCT06878222Phase 2Recruiting

Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC

Role: lead

NCT04516616Phase 2Active Not Recruiting

Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer

Role: collaborator